论文部分内容阅读
The point mutations in the active-site arginine residues of isocitrate dehydrogenase (IDH) (IDH 1/R 132, IDH2/R 140, and IDH2/R 172) occur frequently in a variety of cancers, including acute myeloid leukemia (AML), brain tumors,and holangiocarcinomas.